Skinvisible's value lies in its ability to continually generate new IP on dermatology and medical products formulated with Invisicare®. Patent approvals are sought (initially in the U.S. and later internationally) for all products developed. There are 4 patents approved, 9 U.S. patents pending in addition to 34 PCTs internationally, with many more to be filed. Some of these PCT patents cover up to five products. All patents with Invisicare® are owned by Skinvisible.

Patent Components (Combined or Individually):

Granted Patents & Trademarks

United States Patents Granted

United States Patent No.: 6,756,059
Granted: June 29, 2004
Topical composition, topical composition precursor, and methods for manufacturing and using.

United States Patent No.: 6,582,683
Granted: June 24, 2003
Dermal barrier composition.

International Patents Granted

India Patent
Granted: July 26, 2007
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Australia Patent
Granted: June 3, 2008
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Japan Patent
Granted: October 31, 2008
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

China Patent
Granted: July 1, 2009
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Korea Patent
Granted: February 9, 2010
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Hong Kong Patent
Granted: July 27, 2010
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Latest Press Releases:

July 27, 2010
Skinvisible's Invisicare Patent Portfolio Strengthens - Hong Kong Patent Granted for Polymer Technology

July 20, 2010
Skinvisible Signs DermSafe Agreement for Europe and China - RHEI Pharmaceuticals Adds Alcohol-Free Hand Sanitizer to Its Product Line

July 13, 2010
Skinvisible Licenses Invisicare Products for US, China and Europe - Rhei Pharmaceuticals Receives Exclusivity for Three Skincare Formulations

April 13, 2010
Skinvisible Signs Development Agreement for Prescription Product for Women's Healthcare - Women's Choice Pharmaceuticals chooses Invisicare for new products

CLICK HERE TO READ ALL NEWS RELEASES

Research & Development

Technology Overview